European Journal of Dermatology

, Volume 28, Issue 5, pp 606–612 | Cite as

Susceptibility of epithelial tumour cell lines to hyperthermia

  • Zheng-Xiu Li
  • He-Xiao Wang
  • Yang Yang
  • Rui-Qun Qi
  • Yi-Lei Li
  • Ai-Jiao Yu
  • Xing-Hua GaoEmail author
Investigative report



Human skin or mucosa exposes cells to both an internal and exogeneous thermal environment and the cells survive within a certain range of temperature. Exogeneous hyperthermia has been applied for the treatment of various types of cancers, fungal disease, and warts.


To determine whether different cellular components in the skin adapt to hyperthermic conditions differentially and further elucidate the mechanisms involved.

Materials & methods

Cell lines derived from normal and tumour epithelial cells were treated with hyperthermic conditions and tested for viability (using an MTS assay), apoptosis (using a FITC-conjugated annexin V apoptosis detection kit), and changes in intracellular calcium (using a calcium-sensitive fluorescent singlewavelength dye, Fluo-4 AM).


Thermo-resistance of different cell types was different when cells were subjected to heat at 45◦C for 30 minutes. Stronger effects of hyperthermia were noted on cell viability and apoptosis in epidermal cells relative to their malignant counterparts, except for cell lines harbouring human papillomavirus (HPV). Hyperthermia had a much greater effect on cell viability and apoptosis in a HPV-negative cell line compared to HPV-positive cell lines. We further found that hyperthermia treatment resulted in a strong calcium influx which led to apoptotic cells. However, no obvious increase in apoptosis was observed in cells treated with the CRAC channel selective inhibitor, BTP2, before application of hyperthermia in all cell types, except three cervical cell lines harbouring HPV.


We propose that hyperthermia results in a CRAC-related strong calcium influx which induces apoptosis, with the exception of HPV-positive cells.

Key words

hyperthermia CRAC channel calcium influx apoptosis HPV 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hegyi G, Szigeti GP, Szasz A. Hyperthermia versus oncothermia: cellular effects in complementary cancer therapy. Evid Based Complement Alternat Med 2013; 2013: 672873.CrossRefGoogle Scholar
  2. 2.
    Datta NR, Rogers S, Klingbiel D, et al. Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta–analyses. Int J Hyperthermia 2016; 32: 809–21.CrossRefGoogle Scholar
  3. 3.
    Soria F, Allasia M, Oderda M, Gontero P. Hyperthermia for non–muscle invasive bladder cancer. Expert Rev Anticancer Ther 2016; 16: 313–21.CrossRefGoogle Scholar
  4. 4.
    Gao S, Zheng M, Ren X, Tang Y, Liang X. Local hyperthermia in head and neck cancer: mechanism, application and advance. Oncotarget 2016; 7: 57367–78.Google Scholar
  5. 5.
    Wang HX, Yang Y, Guo H, et al. HSPB1 deficiency sensitizes melanoma cells to hyperthermia induced cell death. Oncotarget 2016; 7: 67449–62.Google Scholar
  6. 6.
    Takahashi S, Masahashi T, Maie O. Local thermotherapy in sporotrichosis. Hautarzt 1982; 32: 525–8.Google Scholar
  7. 7.
    Gao XH, Gao D, Sun XP, et al. Non–ablative controlled local hyperthermia for common warts. Chin Med J (Engl) 2009; 122: 2061–3.Google Scholar
  8. 8.
    Huo W, Gao XH, Sun XP, et al. Local hyperthermia at 44 degrees C for the treatment of plantar warts: a randomized, patient–blinded, placebo–controlled trial. J Infect Dis 2010; 201: 1169–72.CrossRefGoogle Scholar
  9. 9.
    Mouratidis PX, Rivens I, Ter Haar G. A study of thermal doseinduced autophagy, apoptosis and necroptosis in colon cancer cells. Int J Hyperthermia 2015; 31: 476–88.CrossRefGoogle Scholar
  10. 10.
    Vig M, Kinet JP. Calcium signaling in immune cells. Nat Immunol 2009; 10: 21–7.CrossRefGoogle Scholar
  11. 11.
    Cahalan MD. STIMulating store–operated Ca(2+) entry. Nat Cell Biol 2009; 11: 669–77.CrossRefGoogle Scholar
  12. 12.
    Xiao B, Coste B, Mathur J, Patapoutian A. Temperature–dependent STIM1 activation induces Ca(2)+ influx and modulates gene expression. Nat Chem Biol 2011; 7: 351–8.CrossRefGoogle Scholar
  13. 13.
    Mancarella S, Wang Y, Gill DL. Signal transduction: STIM1 senses both Ca(2)+ and heat. Nat Chem Biol 2011; 7: 344–5.CrossRefGoogle Scholar
  14. 14.
    Umemura M, Baljinnyam E, Feske S, et al. Store–operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration. PLoS One 2014; 9: e89292.CrossRefGoogle Scholar
  15. 15.
    Chen YF, Chiu WT, Chen YT, et al. Calcium store sensor stromalinteraction molecule 1–dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc Natl Acad Sci USA 2011; 108: 15225–30.CrossRefGoogle Scholar
  16. 16.
    Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309–12.CrossRefGoogle Scholar
  17. 17.
    Honda H, Kondo T, Zhao QL, Feril LB Jr., Kitagawa H. Role of intracellular calcium ions and reactive oxygen species in apoptosis induced by ultrasound. Ultrasound Med Biol 2004; 30: 683–92.CrossRefGoogle Scholar
  18. 18.
    Fajardo LF, Egbert B, Marmor J, Hahn GM. Effects of hyperthermia in a malignant tumor. Cancer 1980; 45: 613–23.CrossRefGoogle Scholar
  19. 19.
    Tamm I, Wang Y, Sausville E, et al. IAP–family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58: 5315–20.Google Scholar
  20. 20.
    Branca M, Giorgi C, Santini D, et al. Survivin as a marker of cervical intraepithelial neoplasia and high–risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol 2005; 124: 113–21.CrossRefGoogle Scholar
  21. 21.
    Frost M, Jarboe EA, Orlicky D, et al. Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol 2002; 117: 738–44.CrossRefGoogle Scholar
  22. 22.
    Honegger A, Leitz J, Bulkescher J, Hoppe–Seyler K, Hoppe–Seyler F. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV–positive cancer cells. Int J Cancer 2013; 133: 1631–42.CrossRefGoogle Scholar
  23. 23.
    Borbely AA, Murvai M, Konya J, et al. Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J Gen Virol 2006; 87: 287–94.CrossRefGoogle Scholar
  24. 24.
    Saxena A, Yashar C, Taylor DD, Gercel–Taylor C. Cellular response to chemotherapy and radiation in cervical cancer. Am J Obstet Gynecol 2005; 192: 1399–403.CrossRefGoogle Scholar
  25. 25.
    Milrot E, Jackman A, Kniazhanski T, et al. Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin. Cancer Lett 2012; 319: 31–8.CrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Zheng-Xiu Li
    • 1
  • He-Xiao Wang
    • 1
  • Yang Yang
    • 1
  • Rui-Qun Qi
    • 1
  • Yi-Lei Li
    • 1
  • Ai-Jiao Yu
    • 1
  • Xing-Hua Gao
    • 1
    Email author
  1. 1.Department of DermatologyThe First Hospital of China Medical UniversityShenyangChina

Personalised recommendations